The only drugs administered to the public are those that have been investigated and thus approved by the U.S. Food and Drug Administration (FDA). This can often be a long and uphill battle, taking many drugs years to reach consumers. However, when the already approved medications given to a terminally ill patient aren’t working, many are arguing that they should have a “right to try” medications that have not received final approval from the FDA.
Twenty-two states in the United States have already approved this law and other states are following. These “right to try” laws state that under correct protocol, terminally ill patients have the right to drugs not approved by the FDA. When a patient has tried all other treatment options and still remains in critical condition, this new law can offer some hope if an unapproved drug can possibly help. Some are saying this law gives some hope to those who have lost all. If some patients were forced to wait until the drug was approved by the FDA, many would die before the process was complete.
“Right to try” activists are calling for the new law to be approved in more states. Some states have even seen unanimous votes in the House and Senate in approval of the law. According to families of terminally ill patients such as Dalton Powers, whose dad suffers from ALS, this new law has allowed access to treatments and medications that may not be officially approved for 10 more years. Due to reasons such as this, it seems as though more states will move forward with “right to try” laws.